Vulvar Malignant Melanoma: A Narrative Review

Malignant melanoma is a fatal disease that affects all skin sites. Among these, vulvar melanoma (VM) is a rare gynecological condition that accounts for 5% of all vulvar neoplasms. VM primarily affects older Caucasian women and its relationship to sun exposure is undefined. Diagnosis is defined by b...

Full description

Bibliographic Details
Main Authors: Giovanni Falcicchio, Lorenzo Vinci, Ettore Cicinelli, Vera Loizzi, Francesca Arezzo, Erica Silvestris, Leonardo Resta, Gabriella Serio, Gerardo Cazzato, Marialuigia Mastronardi, Michele Mongelli, Marco Marinaccio, Gennaro Cormio
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/21/5217
_version_ 1797468891920728064
author Giovanni Falcicchio
Lorenzo Vinci
Ettore Cicinelli
Vera Loizzi
Francesca Arezzo
Erica Silvestris
Leonardo Resta
Gabriella Serio
Gerardo Cazzato
Marialuigia Mastronardi
Michele Mongelli
Marco Marinaccio
Gennaro Cormio
author_facet Giovanni Falcicchio
Lorenzo Vinci
Ettore Cicinelli
Vera Loizzi
Francesca Arezzo
Erica Silvestris
Leonardo Resta
Gabriella Serio
Gerardo Cazzato
Marialuigia Mastronardi
Michele Mongelli
Marco Marinaccio
Gennaro Cormio
author_sort Giovanni Falcicchio
collection DOAJ
description Malignant melanoma is a fatal disease that affects all skin sites. Among these, vulvar melanoma (VM) is a rare gynecological condition that accounts for 5% of all vulvar neoplasms. VM primarily affects older Caucasian women and its relationship to sun exposure is undefined. Diagnosis is defined by biopsy but many clinical, dermatoscopic, and confocal microscopic features can guide doctors. The molecular profile is characterized by the KIT mutation, revealed by all of the technologies that are used (classical sequencing, next-generation sequencing, and immunohistochemical staining). BRAF and NRAS mutations are also common in VM. All of these mutations are possible therapeutic targets. Today, surgery remains the first treatment choice for primary VM. The role of neoadjuvant and adjuvant therapy is scarce and the treatment of relapses is widely debated.
first_indexed 2024-03-09T19:13:45Z
format Article
id doaj.art-ee02097463f94a9491e81b5da33d7fb0
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T19:13:45Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-ee02097463f94a9491e81b5da33d7fb02023-11-24T04:00:57ZengMDPI AGCancers2072-66942022-10-011421521710.3390/cancers14215217Vulvar Malignant Melanoma: A Narrative ReviewGiovanni Falcicchio0Lorenzo Vinci1Ettore Cicinelli2Vera Loizzi3Francesca Arezzo4Erica Silvestris5Leonardo Resta6Gabriella Serio7Gerardo Cazzato8Marialuigia Mastronardi9Michele Mongelli10Marco Marinaccio11Gennaro Cormio12Section of Gynecology and Obstetrics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Gynecology and Obstetrics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Gynecology and Obstetrics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Gynecology and Obstetrics, Interdisciplinar Department of Medicine, University of Bari “Aldo Moro”, 70124 Bari, ItalyGynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, ItalyGynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Gynecology and Obstetrics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Gynecology and Obstetrics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari “Aldo Moro”, 70124 Bari, ItalySection of Gynecology and Obstetrics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari “Aldo Moro”, 70124 Bari, ItalyGynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, ItalyMalignant melanoma is a fatal disease that affects all skin sites. Among these, vulvar melanoma (VM) is a rare gynecological condition that accounts for 5% of all vulvar neoplasms. VM primarily affects older Caucasian women and its relationship to sun exposure is undefined. Diagnosis is defined by biopsy but many clinical, dermatoscopic, and confocal microscopic features can guide doctors. The molecular profile is characterized by the KIT mutation, revealed by all of the technologies that are used (classical sequencing, next-generation sequencing, and immunohistochemical staining). BRAF and NRAS mutations are also common in VM. All of these mutations are possible therapeutic targets. Today, surgery remains the first treatment choice for primary VM. The role of neoadjuvant and adjuvant therapy is scarce and the treatment of relapses is widely debated.https://www.mdpi.com/2072-6694/14/21/5217vulvar melanomarare gynecological cancertarget treatment
spellingShingle Giovanni Falcicchio
Lorenzo Vinci
Ettore Cicinelli
Vera Loizzi
Francesca Arezzo
Erica Silvestris
Leonardo Resta
Gabriella Serio
Gerardo Cazzato
Marialuigia Mastronardi
Michele Mongelli
Marco Marinaccio
Gennaro Cormio
Vulvar Malignant Melanoma: A Narrative Review
Cancers
vulvar melanoma
rare gynecological cancer
target treatment
title Vulvar Malignant Melanoma: A Narrative Review
title_full Vulvar Malignant Melanoma: A Narrative Review
title_fullStr Vulvar Malignant Melanoma: A Narrative Review
title_full_unstemmed Vulvar Malignant Melanoma: A Narrative Review
title_short Vulvar Malignant Melanoma: A Narrative Review
title_sort vulvar malignant melanoma a narrative review
topic vulvar melanoma
rare gynecological cancer
target treatment
url https://www.mdpi.com/2072-6694/14/21/5217
work_keys_str_mv AT giovannifalcicchio vulvarmalignantmelanomaanarrativereview
AT lorenzovinci vulvarmalignantmelanomaanarrativereview
AT ettorecicinelli vulvarmalignantmelanomaanarrativereview
AT veraloizzi vulvarmalignantmelanomaanarrativereview
AT francescaarezzo vulvarmalignantmelanomaanarrativereview
AT ericasilvestris vulvarmalignantmelanomaanarrativereview
AT leonardoresta vulvarmalignantmelanomaanarrativereview
AT gabriellaserio vulvarmalignantmelanomaanarrativereview
AT gerardocazzato vulvarmalignantmelanomaanarrativereview
AT marialuigiamastronardi vulvarmalignantmelanomaanarrativereview
AT michelemongelli vulvarmalignantmelanomaanarrativereview
AT marcomarinaccio vulvarmalignantmelanomaanarrativereview
AT gennarocormio vulvarmalignantmelanomaanarrativereview